The pursuit of outperformance leads many investors to carefully choose individual stocks. Picking the right ones can be a game-changer for growing your wealth.
In the latest session, Unitedhealth Group Inc (NYSE: UNH) closed at $333.93 down -1.93% from its previous closing price of $340.51. In other words, the price has decreased by -$1.93 from its previous closing price. On the day, 5.58 million shares were traded. UNH stock price reached its highest trading level at $341.8439 during the session, while it also had its lowest trading level at $332.85.
Ratios:
For a deeper understanding of Unitedhealth Group Inc’s stock, let’s take a closer look at its various ratios. In the meantime, Its Debt-to-Equity ratio is 0.84 whereas as Long-Term Debt/Eq ratio is at 0.76.
On October 14, 2025, Goldman started tracking the stock assigning a Buy rating and target price of $406.
Robert W. Baird Downgraded its Neutral to Underperform on July 31, 2025, while the target price for the stock was maintained at $198.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Sep 11 ’25 when Baker Charles D. sold 27 shares for $356.05 per share. The transaction valued at 9,613 led to the insider holds 0 shares of the business.
James P Schadt Trust FBO Laure bought 27 shares of UNH for $9,363 on Sep 11 ’25. On Jun 10 ’25, another insider, Conway Patrick Hugh, who serves as the Chief Executive Officer, Optum of the company, sold 589 shares for $305.00 each. As a result, the insider received 179,645 and left with 10,398 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, UNH now has a Market Capitalization of 302486683648 and an Enterprise Value of 362034692096. As of this moment, Unitedhealth’s Price-to-Earnings (P/E) ratio for their current fiscal year is 17.43, and their Forward P/E ratio for the next fiscal year is 18.83. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.70 while its Price-to-Book (P/B) ratio in mrq is 3.16. Its current Enterprise Value per Revenue stands at 0.832 whereas that against EBITDA is 12.381.
Stock Price History:
The Beta on a monthly basis for UNH is 0.42, which has changed by -0.37339443 over the last 52 weeks, in comparison to a change of 0.1726681 over the same period for the S&P500. Over the past 52 weeks, UNH has reached a high of $606.36, while it has fallen to a 52-week low of $234.60. The 50-Day Moving Average of the stock is 1.16%, while the 200-Day Moving Average is calculated to be -2.52%.
Shares Statistics:
For the past three months, UNH has traded an average of 7.34M shares per day and 6112280 over the past ten days. A total of 906.00M shares are outstanding, with a floating share count of 904.05M. Insiders hold about 0.20% of the company’s shares, while institutions hold 83.85% stake in the company. Shares short for UNH as of 1767139200 were 13909868 with a Short Ratio of 1.90, compared to 1764288000 on 12939301. Therefore, it implies a Short% of Shares Outstanding of 13909868 and a Short% of Float of 1.54.
Dividends & Splits
According to the company, the forward annual dividend rate for UNH is 8.73, from 8.62 in the trailing year. Against a Trailing Annual Dividend Yield of 0.025314968. The stock’s 5-year Average Dividend Yield is 1.53. The current Payout Ratio is 52.75% for UNH, which recently paid a dividend on 2025-12-08 with an ex-dividend date of 2025-12-08. Stock splits for the company last occurred on 2005-05-31 when the company split stock in a 2:1 ratio.
Earnings Estimates
Currently, 24.0 analysts are dedicated to thoroughly evaluating and rating the performance of Unitedhealth Group Inc (UNH) in the stock market.The consensus estimate for the next quarter is $6.66, with high estimates of $8.05 and low estimates of $5.03.
Analysts are recommending an EPS of between $16.5 and $16.23 for the fiscal current year, implying an average EPS of $16.32. EPS for the following year is $17.75, with 28.0 analysts recommending between $19.31 and $17.05.
Revenue Estimates
A total of 19 analysts believe the company’s revenue will be $113.73B this quarter.It ranges from a high estimate of $118B to a low estimate of $112.25B. As of. The current estimate, Unitedhealth Group Inc’s year-ago sales were $100.81BFor the next quarter, 19 analysts are estimating revenue of $113.68B. There is a high estimate of $117.11B for the next quarter, whereas the lowest estimate is $107.8B.
A total of 24 analysts have provided revenue estimates for UNH’s current fiscal year. The highest revenue estimate was $452.31B, while the lowest revenue estimate was $446.6B, resulting in an average revenue estimate of $447.99B. In the same quarter a year ago, actual revenue was $400.28BBased on 24 analysts’ estimates, the company’s revenue will be $455.98B in the next fiscal year. The high estimate is $475.8B and the low estimate is $426.52B.
